Volume | 31,623 |
|
|||||
News | - | ||||||
Day High | 2.25 | Low High |
|||||
Day Low | 2.1281 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Check Cap Ltd | CHEK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.22 | 2.1281 | 2.25 | 2.18 | 2.22 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
163 | 31,623 | $ 2.22 | $ 70,189 | - | 1.27 - 4.625 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:11:57 | 1 | $ 2.13 | USD |
Check Cap Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.69M | 5.85M | - | 0 | -19.11M | -3.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Check Cap News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.41 | 2.55 | 2.1281 | 2.32 | 30,237 | -0.23 | -9.54% |
1 Month | 1.87 | 3.45 | 1.82 | 2.50 | 787,543 | 0.31 | 16.58% |
3 Months | 2.20 | 3.45 | 1.78 | 2.48 | 271,996 | -0.02 | -0.91% |
6 Months | 3.30 | 3.937 | 1.78 | 2.50 | 137,170 | -1.12 | -33.94% |
1 Year | 1.37 | 4.625 | 1.27 | 2.64 | 112,018 | 0.81 | 59.12% |
3 Years | 29.60 | 38.178 | 1.22 | 17.75 | 721,936 | -27.42 | -92.64% |
5 Years | 47.80 | 89.80 | 1.22 | 29.59 | 2,234,813 | -45.62 | -95.44% |
Check Cap Description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |